GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Deferred Tax

CK Life Sciences International Holdings (HKSE:00775) Deferred Tax : HK$0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

CK Life Sciences International Holdings's change in deferred tax for the six months ended in Dec. 2023 was HK$0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.

CK Life Sciences International Holdings Deferred Tax Historical Data

The historical data trend for CK Life Sciences International Holdings's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Deferred Tax Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CK Life Sciences International Holdings Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings Deferred Tax Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Deferred Tax
Comparable Companies
HKSE:02171 HKSE:01521 HKSE:02511 HKSE:02179 HKSE:02105 HKSE:09966 HKSE:02487 HKSE:01477 HKSE:02256 HKSE:03681 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
LSI:Germany
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
Website
https://www.ck-lifesciences.com
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines